Refining prognosis and identifying targetable pathways for high-risk endometrial cancer: a TransPORTEC initiative.

Stelloo, Ellen, Bosse, Tjalling, Nout, Remi A, MacKay, Helen J, Church, David N, Nijman, Hans W, Leary, Alexandra, Edmondson, Richard J +7 more·2015·Modern Pathology
DOI 10.1038/modpathol.2015.43

Cited by (491)

Items 301–400 of 491

  1. An update of molecular pathology and shifting systems of classification in tumours of the female genital tract
    Noorah Almadani, Emily F. Thompson, Basile Tessier‐Cloutier, Jennifer Pors, Lynn N. Hoang · 2020 · Diagnostic histopathology
  2. Sentinel Lymph Node Biopsy in Surgical Staging for High-Risk Groups of Endometrial Carcinoma Patients
    Antonio Raffone, Diego Raimondo, Antonio Travaglino, Giulia Rovero, Manuela Maletta, Ivano Raimondo, Marco Petrillo, Giampiero Capobianco, Paolo Casadio, Renato Seracchioli et al. · 2022 · International Journal of Environmental Research and Public Health
  3. ProMisE on the horizon: molecular classification of endometrial cancer in young women
    Stephanie L. Wethington, Amanda N. Fader · 2019 · Gynecologic Oncology
  4. Comparative Analysis of Somatic and Germline Polymerase Proofreading Deficiencies in Cancer: Molecular and Clinical Implications
    Julen Viana-Errasti, Raúl Marín, Sandra García‐Mulero, Tirso Pons, Mariona Terradas, Gabriel Capellá, Victor Rau Moreno, Pilar Mur, Laura Valle · 2025 · Modern Pathology
  5. Interpretable prognostic modeling of endometrial cancer
    Bulat Zagidullin, Annukka M. Pasanen, Mikko J. Loukovaara, Ralf C. Bützow, Jing Ping Tang · 2022 · Scientific Reports
  6. p53 Immunohistochemical Staining and TP53 Gene Mutations in Endometrial Cancer
    Ikuko Sakamoto, Keiko Kagami, Takahiro Nozaki, Yosuke Hirotsu, Kenji Amemiya, Toshio Oyama, Masao Omata · 2023 · The American Journal of Surgical Pathology
  7. Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in CTNNB1 -mutated endometrial cancer
    Bradley R. Corr, Marisa R. Moroney, Elizabeth R. Woodruff, Zachary L. Watson, Kimberly Rae Jordan, Thomas Danhorn, Courtney A. Bailey, Rebecca J. Wolsky, Benjamin Guy Bitler · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Biomolecular Classification in Endometrial Cancer: Onset, Evolution, and Further Perspectives: A Critical Review
    Valentina Bruno, Martina Betti, Jessica Mauro, Alessandro Antonio Buda, Enrico Vizza · 2024 · Cancers
  9. HER2 expression in an endometrial cancer cohort
    Kari Hacker, Kathryn A Fleming, Mamta Gupta, Bhavana Pothuri · 2025 · Gynecologic Oncology
  10. Re-stratification of patients with copy-number low endometrial cancer by clinicopathological characteristics
    Li Liwei, He Li, Dai Yibo, Zhao Luyang, Zhihui Shen, Kang Nan, Shen Danhua, Wang Junzhu, Wang Zhiqi, Jianliu Wang · 2023 · World Journal of Surgical Oncology
  11. An Innovative and Accurate Next-Generation Sequencing–Based Microsatellite Instability Detection Method for Colorectal and Endometrial Tumors
    Camille Evrard, Ulrich Cortes, Birama Ndiaye, Justine Bonnemort, Marine Martel, Roxanne Aguillon, David Tougeron, Lucie Karayan · 2023 · Laboratory Investigation
  12. Prognostic Significance of the Immune Microenvironment in Endometrial Cancer
    Miseon Lee, Wonkyung Jung, Jeongseok Kang, Keun Ho Lee, Sung Jong Lee, Sook Hee Hong, Jun Kyu Kang, Ahwon Lee · 2024 · Laboratory Investigation
  13. The clinical utility of next generation sequencing in endometrial cancer: focusing on molecular subtyping and lynch syndrome
    Yongzhen Guo, Guangwei Yan, Pei Zhang, Yixuan Liu, Chengquan Zhao, Xianxu Zeng · 2024 · Frontiers in Genetics
  14. Meta‐analysis of the ability of mutational profiles on the cancer genome atlas to predict prognosis in endometrial carcinoma
    Y. Li, Yu Jing Fan, Shiyu Cao, Yu‐fei Zhang, J.P. Li · 2025 · International Journal of Gynecology & Obstetrics
  15. Clinicopathologic Evaluation of CTNNB1 Mutations in High-Intermediate Risk Endometrial Endometrioid Carcinoma
    Jennifer G. Haag, Rebecca J. Wolsky, Marisa R. Moroney, Jamie Sheren, Jeanelle L. Sheeder, Benjamin G. Bitler, Bradley R. Corr · 2022 · International Journal of Gynecological Pathology
  16. PROTACs in gynecological cancers: Current knowledge and future potential as a treatment strategy
    Fatemeh Movahed, Zahra Ourang, Razieh Neshat, Wael Sheet Hussein, Anwar Salih Saihood, Maythum Shallan Alarajy, Donya Zareii · 2024 · Pathology - Research and Practice
  17. Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping
    Nick M. Baniak, C. Blake Gilks, John F. DeCoteau, Mary A. Kinloch · 2019 · International Journal of Gynecological Pathology
  18. Implementation of the 2021 molecular ESGO/ESTRO/ESP risk groups in endometrial cancer
    Sara Imboden, Denis Nastic, Mehran Ghaderi, Filippa Rydberg, Franziska Siegenthaler, Michael David Mueller, Tilman T. Rau, E. Epstein, Joseph W. Carlson · 2021 · medRxiv
  19. Molecular diversity in uterine carcinosarcoma: Beyond TP53
    Eveline Ngoc Bao Pham, Caroline B. van den Berg, Nina Kokke, Ronald van Marion, Dennis Dollée, Ingrid A Boere, Floris H. Groenendijk, Heleen J. van Beekhuizen · 2025 · Gynecologic Oncology
  20. TCGA molecular subtypes in endometriosis-associated ovarian cancer: a systematic review and meta-analysis
    Luxin Ye, Jiahui Chen, Wenwen Guo, Qian Zhao, Xianzhong Cheng, Xuening Wang, Xia Xu, Xiaoxiang Chen, Jing Ni · 2025 · Annals of Medicine
  21. AQB improves carboplatin sensitivity in endometrial cancer through dual DNA repair modulation: suppression of the p21-E2F1-RAD51 and ATF3-HDAC1-BRCA1 signaling
    Xingyu Zheng, Eryan Yang, Ye Yan, Shuangshuang Zhao, Xianxian Li, Tianqi Wang, Yuening Piao, Wei Liu, Jiaxin Chen, Sitong Wen et al. · 2025 · Cell Death and Disease
  22. Diagnostic Challenges and Clinical Implications of Microsatellite Instability/Mismatch Repair Deficiency in Solid Tumors
    Yoonjin Kwak, Jeong Mo Bae, Hye Seung Lee · 2025 · Cancer Research and Treatment
  23. Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry—Real-World Implementation and Results at a Tertiary Care Center
    Kurtis D. Davies, Lynelle P. Smith, Amy Guimarães-Young, Bradley R. Corr, Christine M. Fisher, Saketh R. Guntupalli, Amber A. Berning, Miriam D. Post, Devon Pino, Dara L. Aisner et al. · 2023 · International Journal of Gynecological Pathology
  24. Morules and β-catenin predict POLE mutation status in endometrial cancer: A pathway to more cost-effective diagnostic procedures
    Rujia Fan, Wanrun Lin, Ruijiao Zhao, Li Li, Rui Xin, Yunfeng Zhang, Yuxin Liu, Ying Ma, Yiying Wang, Yue Wang et al. · 2024 · American Journal of Clinical Pathology
  25. The prognostic implication of polymerase epsilon-mutated endometrial cancer
    Kai‐Hung Wang, Dah‐Ching Ding · 2024 · Tzu Chi Medical Journal
  26. Next-generation sequencing in the molecular classification of endometrial carcinomas: Experience with 270 cases suggesting a potentially more aggressive clinical behavior of multiple classifier endometrial carcinomas
    Květoslava Michalová, Andrea Straková Peteříková, Ondřej Ondič, Tomáš Vaněček, Michael Michal, Nikola Hejhalová, Petr Holub, Petr Slavík, Adam Hluchý, Polina Gettse et al. · 2024 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  27. Molecular subtyping of endometrial cancer via a simplified one-step NGS classifier, ARID1A and ZFHX4 mutations help further subclassify CNL/MSI-H patients
    Qiuli Teng, Zeng Yuan, Yulong Mu, Xinyue Ma, Shuaixin Wang, Chenggong Sun, Linhan Chin, Zhan Huang, Changbin Zhu, Aijun Yin et al. · 2025 · Diagnostic Pathology
  28. L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma
    Damiano Arciuolo, Antonio Travaglino, Angela Santoro, Giulia Scaglione, Nicoletta D’Alessandris, Michele Valente, Frediano Socrate Inzani, Rossella Accarino, Alessia Piermattei, Roberta Benvenuto et al. · 2022 · Cancers
  29. Recent progress in the use of pharmacotherapy for endometrial cancer
    Elena Giudice, Vanda Salutari, Caterina Ricci, Camilla Nero, Maria Vittoria Carbone, Lucia Musacchio, Viola Ghizzoni, Maria Teresa Perri, Floriana Camarda, Francesca Tronconi et al. · 2022 · Expert Opinion on Pharmacotherapy
  30. Is p53 immunohistochemistry alone useful for delineating adjuvant endometrial treatment in low-middle-income countries?
    Eduardo Paulino, Luana Marquarte Santana, Guilherme Gomes de Mesquita, Andréia Cristina de Melo · 2024 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  31. Traditional Approaches to Molecular Genetic Analysis
    Christopher James Walker, Paul J. Goodfellow · 2016 · Advances in experimental medicine and biology
  32. Adenomatous Polyposis Syndromes: Polymerase Proofreading-Associated Polyposis
    Claire Palles, Andrew R. Latchford, Laura Valle · 2018 · Springer eBooks
  33. Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?
    Stephanie Ka-Yee Chow, Deanna H. Wong, Cheng-I Liao, Amandeep Kaur Mann, Chunqiao Tian, Kathleen M. Darcy, John K. Chan · 2020 · Journal of Gynecologic Oncology
  34. Clinical relevance of high–intermediate risk endometrial cancer according to European risk classification
    Agnieszka Rychlik, Ignacio Zapardiel, Laura Baquedano, María Ángeles Martínez Maestre, Denis Querleu, Pluvio Coronado · 2020 · International Journal of Gynecological Cancer
  35. Histomolecular features of high-grade endometrial cancers
    Matteo Morotti, Hooman Soleymani majd, Jvan Casarin, Móiad Alazzam, Stephen Damato · 2021 · Minerva Medica
  36. Molecular Prognostic Factors in Uterine Serous Carcinomas: A Systematic Review
    Anna Svarna, Michalis Liontos, Alkistis Maria Papatheodoridi, Αριστέα-Μαρία Παπανώτα, Eleni Zografos, Μαρία Καπαρέλου, Flora Zagouri, Meletios Athanasios Dimopoulos · 2025 · Current Oncology
  37. Chinese expert consensus on clinical application of molecular classification of endometrial cancer (2024)
    Yangyang Dong, Luyang Zhao, Nan Kang, Yiqin Wang, He Li, Zhiqi Wang, Jianliu Wang · 2025 · Gynecology and Obstetrics Clinical Medicine
  38. ENDOESTRO score: Where is the dark side? Evaluation of estrogen receptor expression cutoff in endometrial cancer molecular classification, an ambispective study
    Emanuele Perrone, Ettore Distefano, Emilia Palmieri, Diana Giannarelli, Ilaria Capasso, Alessandra Giustozzi, Giuseppe Parisi, Giovanni Esposito, Maria Consiglia Giuliano, Vincenzo Tarantino et al. · 2025 · European Journal of Cancer
  39. Cell state dynamics during early stages of serous endometrial carcinoma
    Andrea Flesken‐Nikitin, Matalin G. Pirtz, Christopher S. Ashe, Lora Hedrick Ellenson, Anna V. Yemelyanova, Benjamin D. Cosgrove, Alexander Yu. Nikitin · 2025 · The Journal of Pathology
  40. Application of nanoparticles in the therapeutic management of endometrial cancer
    Da Ke, Wenzhe Li, Qian Chen, Liang Luo, Ya Wang, Fanling Meng, Yaling Sun · 2026 · European journal of medical research
  41. Consenso colombiano para el diagnóstico molecular del cáncer de endometrio
    Marc Edy Pierre, Angélica V Fletcher, Juliana Rodríguez, Abraham Hernández-Blanquisett, Ana Milena Gómez, Rafael Parra Medina, Lucrecia Mojica Silva, Róbinson Fernández-Mercado, Pedro Hernando Calderón-Quiroz · 2024 · Revista Colombiana de Obstetricia y Ginecología
  42. Molecular classification of endometrial cancer: preliminary experience from a single Portuguese academic center
    João Casanova, Ana Gomes da Costa, Ana Pestana Lopes, Ana Catarino, Mónica Nave, Ana Carla Sousa, Jorge José Albuquerque Vieira de Lima · 2024 · Pathology & Oncology Research
  43. The prognostic potential of molecular subtypes including estrogen receptor status in endometrioid ovarian cancer
    Hein S. Zelisse, Malou L.H. Snijders, Floris H. Groenendijk, Johannes B.G. Halfwerk, Gerrit K. J. Hooijer, Willemien J. van Driel, Alicia León‐Castillo, Christianne Lok, Loes F. S. Kooreman, Sandrina Lambrechts et al. · 2025 · Gynecologic Oncology
  44. Molecular risk stratification to direct therapy in endometrial cancer: ready for the clinic?
    Carien L. Creutzberg, Tjalling Bosse · 2018 · Annals of Oncology
  45. Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma
    Asmerom Tesfamariam Sengal, Deborah S. Smith, Cameron Edward Snell, Samuel C. Y. Leung, Aline Talhouk, Elizabeth D. Williams, Jessica Nell McAlpine, Pamela M. Pollock · 2022 · The Journal of Pathology Clinical Research
  46. It is time to implement molecular classification in endometrial cancer
    Valentina Bruno, Alessandra Logoteta, Benito Chiofalo, Emanuela Mancini, Martina Betti, Luana Fabrizi, Emilio Piccione, Enrico Vizza · 2023 · Archives of Gynecology and Obstetrics
  47. Serum Proteomic Profiles of Patients with High and Low Risk of Endometrial Cancer Recurrence
    Dagmara Pietkiewicz, Mikołaj Piotr Zaborowski, Kamila Jaz, Eliza Matuszewska, Agata Światły‐Błaszkiewicz, Tomasz Kluz, Zenon Józef Kokot, Ewa Nowak‐Markwitz, Jan Matysiak · 2023 · International Journal of Molecular Sciences
  48. Endometrial Carcinoma
    Tricia A. Murdock, Emanuela F. T. Veras, Robert J. Kurman, Michael T. Mazur · 2018 · Springer eBooks
  49. Development and validation of a prediction model for recurrence based on ProMisE molecular classifier and immune-inflammatory- nutritional score in endometrial carcinoma: a retrospective multiple-center study
    Yunfeng Zheng, Fan Yang, Gaohua Liu, Xixi Wu, Li Xie, Ran Hu, Xiaoxiao Luo, Rui Yuan · 2025 · International Journal of Medical Sciences
  50. Prevalence of high-grade endometrioid endometrial cancer of no specific molecular profile (NSMP): A systematic review and meta-analysis
    João Casanova, Ana Sofia Barroso Frattini Ramos, Alexandru Babiciu, F. Senos Moutinho, Marta Tripepi, Ana Gomes da Costa, Sofia Silvério Serra, Teresa Costa, Nadeem R. Abu‐Rustum, João Paulo Martins et al. · 2025 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  51. Correlation between ultrasonographic findings and histopathological and molecular characteristics in endometrial cancer: A multicenter study
    Irene Colombi, Giuseppe Vizzielli, Eugenia Costantini, Silvia Pisaneschi, Federica Perelli, Anna Biasoli, Stefano Restaino, Francesca Ciccarone, Gabriele Centini, Francesco Giuseppe Martire et al. · 2025 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  52. Exploring Nectin-4 as a potential diagnostic biomarker in endometrial adenocarcinoma
    Melike Ordu, Şerife Özlem Genç · 2025 · BMC Women s Health
  53. Nuclear β-Catenin Expression in the Context of Abnormal p53 Expression Indicates a Nonserous Histotype in Endometrial Carcinoma
    Kianoosh Keyhanian, Eric Yang, Brooke E. Howitt · 2022 · International Journal of Gynecological Pathology
  54. Association of molecular subgroups with pathological parameters in endometrial carcinomas
    Nirosha Ratnakaran, Indu Ramachandran Nair, Anupama Rajanbabu, Viral Patel, Prasanth S. Ariyannur, Sukrishna Kamalasanan Thelakkattusserry · 2023 · Indian Journal of Cancer
  55. Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacy
    Neil A. J. Ryan, Mark A. Glaire, Thomas D. J. Walker, Natalja T. ter Haar, Marieke E. Ijsselsteijn, James Bolton, Noel F.C.C. de Miranda, D. Gareth Evans, David N. Church, Tjalling Bosse et al. · 2024 · BMJ Oncology
  56. p53abn high-risk endometrial cancer with PPP2R1A mutation might not benefit from adjuvant chemotherapy
    Qingxia Zhang, Yue Wang, Dan He, Jingyun Sun, Xin Li, Dong Li, Ying Dong, Yan Zhang, Suxia Wang · 2025 · American Journal of Clinical Pathology
  57. Subclonal loss of DNA mismatch repair proteins in endometrial carcinomas: an unusual pattern with distinct molecular characteristics
    Graziele Bovolim, Sara Oliveira Silva, Bruna Tirapelli Gonçalves, Giovana Tardin Torrezan, Alexandre André Balieiro Anastácio da Costa, Marina De Brot, Dirce Maria Carraro, Marcelo Petrocchi Corassa, Glauco Baiocchi, Louise De Brot · 2025 · International Journal of Gynecological Cancer
  58. An exploratory analysis of driver gene alterations and their potential prognostic relevance in endometrial cancer with POLE exonuclease domain mutations
    Tsai‐Yin Wei, Chao-Chih Wu, Yun-Ting Hsu, Wen-Hsuan Wendy Lin, Li‐Chu Tsai, Dar-Bin Shieh, Chih‐Long Chang · 2025 · Gynecologic Oncology
  59. Molecular testing in endometrial carcinoma – joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists
    Pavel Dundr, David Cibula, Martin Doležel, Pavel Fabián, Jindřich Fínek, Tomáš Jirásek, Radoslav Matěj, Lubos B. Petruzelka, Lukáš Rob, Aleš Ryška et al. · 2021 · Klinicka onkologie
  60. In-silico analysis of TCGA data showing multiple POLE-like favourable subgroups overlapping with TP53 mutated endometrial cancer: Implications for clinical practice in low and middle-income countries
    Damayanti Das Ghosh, Rahul Roy Chowdhury, Rajeswari Dutta, Indranil Mukhopadhyay, Asima Mukhopadhyay, Susanta Roychoudhury · 2023 · Gynecologic Oncology Reports
  61. Functional and therapeutic significant of heat-shock protein 90 (HSP90) in reproductive cancers
    Ben-Zhen He, Liang Wang · 2024 · Clinical & Translational Oncology
  62. Molecular Classification of Endometrial Cancers Using an Integrative DNA Sequencing Panel
    Soyoun Rachel Kim, Leslie E. Oldfield, Raymond H. Kim, Osvaldo Espin‐Garcia, Kathy Chai-Zung Han, Danielle Vicus, Lua Ruhiyyih Eiriksson, Alicia A. Tone, Aaron F. Pollett, Matthew Cesari et al. · 2024 · Journal of Surgical Oncology
  63. Multi-center, international endometrial cancer consortium highlights
    Luigi Antonio De Vitis, Anna Giudici, Vincenzo Tarantino, Stuart Alan Ostby, Kelly H. Bruce, Daniel M. Breitkopf, Alexander Olawaiye, Ramez Nassef Eskander, Robert Louis Coleman, Amir Momeni Boroujeni et al. · 2025 · International Journal of Gynecological Cancer
  64. Laparoscopic posterior pelvic exenteration for primary adenocarcinoma of the rectovaginal septum without associated endometriosis: A case report
    Toshio Fujimoto, Fumie Tanuma, Noriyuki Otsuka, Soromon Kataoka · 2018 · Molecular and Clinical Oncology
  65. Current prerequisites for a molecular genetic classification of endometrial cancer
    Sergey Vladimirovich Vtorushin, R. D. Malykh · 2017 · Russian Journal of Archive of Pathology
  66. Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249
    Lindsay Kuroki, Danielle M. Enserro, Heather A. Lankes, Kyle C. Strickland, Rebecca A. Previs, Aine Clements, Matthew Powell, Ann H. Klopp, Elena Ratner, Paul DiSilvestro et al. · 2025 · Gynecologic Oncology
  67. A prognostic model based on immune cells in tumor microenvironment to predict prognosis in endometrial cancer
    Liwei Li, He Li1, Yangyang Dong, Yibo Dai, Zhihui Shen, Zhuoyu Zhai, Xiaobo Zhang, Danhua Shen, Zhiqi Wang, Jianliu Wang · 2025 · BMC Cancer
  68. Prognostic modeling of endometriosis-associated ovarian cancer based on molecular signatures: a retrospective study
    Ming Wang, Jianqing Xu, Jianfen Cui, Shuiqing Xu, Yue Wu · 2025 · Journal of Ovarian Research
  69. Molecular Classification and Clinical Outcomes in Endometrial Cancer: Real-World Evidence from a Tertiary Care Center
    Tanadon Salakphet, Prapaporn Suprasert, Tip Pongsuvareeyakul, Chinachote Teerapakpinyo, Surapan Khunamornpong · 2026 · Cancers
  70. Prognostic Stratification of Multiple-Classifier Endometrial Cancers: Cohort Study and Meta-Analysis
    Sabrina Paratore, Angela Russo, Katia Lanzafame, Giusi Blanco, Eliana Giurato, Giovanni Bartoloni, Marco D’Asta, Mirella Sapienza, Giulia Maria Bonanno, Antonino Vallone et al. · 2026 · Cancers
  71. Prognostic models for predicting recurrence and survival in women with endometrial cancer
    Yee-Loi Louise Wan, Iman El Sayed, Thomas D. J. Walker, Bryn Russell, Ellena Badrick, Alexandra McAleenan, Richard John Edmondson, Emma Jayne Crosbie · 2021 · Cochrane Database of Systematic Reviews
  72. Molecular pathology of endometrial cancer: recent advances in classification, prognostication, and management
    Mona Alfaraidi, Jutta K. Huvila, C. Blake Gilks · 2024 · Diagnostic histopathology
  73. Development of a disulfidptosis-related prognostic model for endometrial cancer with potential therapeutic target
    Chunmei Li, Xuefei Fan, Xue Wang, Yulan Yao, Bing Huang, Linlin Chen, Lu Cao, Tao Peng, Yingying Lin, Rong Sheng Cai · 2024 · Discover Oncology
  74. Improved Prognostic Stratification With 2023 International Federation of Gynecology and Obstetrics Staging in Endometrial Cancer Reflecting Poor Prognosis of Aggressive Histological Types and p53 Abnormality
    Miseon Lee, Heesoo Yoon, Ujae Kim, Jun Kyu Kang, Yeon Bi Han, Keun Ho Lee, Sung Jong Lee, Sook Hee Hong, Dong Hoon Suh, Kidong Kim et al. · 2025 · Laboratory Investigation
  75. The Prognostic Impact of MLH1 Promoter Hypermethylation in Stage I-II Endometrial Cancer Treated With Adjuvant Radiation Therapy: A Multi-Institutional Retrospective Study
    Zohaib Sherwani, Shari Damast, Emma Charlotte Fields, Sushil Beriwal, Zachary D. Horne, Elizabeth A. Kidd, Eric W. Leung, Neil Kanth Taunk, Junzo Chino, Andrea Lyn Russo et al. · 2025 · International Journal of Radiation Oncology*Biology*Physics
  76. Integrating homologous recombination deficiency subtyping with TCGA molecular classification for enhanced prognostic stratification and personalised therapy in endometrial cancer
    Wei Wang, Min Gao, Yunong Gao, Hong Zheng, Nan Song, Naiyi Zhang, Tong Shu, Weijiao Gao, Nan Zhang, Hongguo Wang · 2025 · British Journal of Cancer
  77. Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: a ENYGO-IJGC Fellows initiative
    Martina Aida Ángeles, Félix Boria, Alexander B Shushkevich, Nicolò Bizzarri, Charalampos Theofanakis, Gabriella Schivardi, Joanna P. Kacperczyk-Bartnik, Aleksandra Natalia Strojna, Esra Bilir, Sven Mahner et al. · 2022 · International Journal of Gynecological Cancer
  78. Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes
    Shengjie Xu, Ridwan Abdifatah Mohamed, Juan Xu, Yao Yao, Yun Gu, Wenwei Tang, Xuemei Jia · 2025 · International Journal of Women s Health
  79. CD73 restrains mutant β-catenin oncogenic activity in endometrial carcinomas
    Rebecca M. Hirsch, Gaith N. Droby, Sunthoshini Premsankar, Molly Parrish, Katherine C. Kurnit, Lilly F. Chiou, Emily M. Rabjohns, Hannah N. Lee, Russell R. Broaddus, Cyrus Vaziri et al. · 2026 · JCI Insight
  80. Endometrial cancer recurrence in the sacrum and the Psoas: A case report and literature review
    Judy Hayek, Rishika Reddy, Gary L. Goldberg, Ioannis Alagkiozidis · 2021 · Gynecologic Oncology Reports
  81. Place des inhibiteurs de PARP dans le traitement des cancers de l’endomètre et du col de l’utérus
    Marjolaine Le Gac, Meriem Koual, Nicolas Delanoy, Géraldine Perkins, Huyên-Thu Nguyen-Xuan, Hélène Blons, Marie‐Aude Le Frère‐Belda, Pierre Laurent‐Puig, Enrica Bentivegna, Catherine Durdux et al. · 2021 · Bulletin du Cancer
  82. Tumor‐infiltrating immune cell score as an independent prognostic predictor for endometrial carcinoma: Insights from a comprehensive analysis of the immune landscape
    Liping Zhang, Qiaoying Zhu, Qi Zhao, Xueping Lin, Hui Kyoung Song, Hong Liu, Guiquan Zhu, Shun Lu, Bangrong Cao · 2023 · Cancer Reports
  83. Molecular Oncology of Gynecologic Tumors
    Isabel Alvarado‐Cabrero · 2020 · Archives of Medical Research
  84. Clinicopathologic characteristics and prognosis comparison of the uterine high grade endometrial carcinomas
    Mete Sucu, Ümran Küçükgöz Güleç, Semra Paydaş, Ahmet Barış Güzel, Emine Kılıç Bağır, Mehmet Ali Vardar · 2021 · Ginekologia Polska
  85. Faculty Opinions recommendation of Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
    Steve Plaxe · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  86. Research Progress on Molecular Typing of Endometrial Carcinoma
    莹花 李 · 2023 · Advances in Clinical Medicine
  87. The Development Process of Endometrial Cancer from Tissue to Molecular Typing
    筱茹 侯 · 2024 · Advances in Clinical Medicine
  88. Clinicopathological Significance of Defective DNA Mismatch Repair in Endometrial Carcinoma: A Single-Center Study From Bahrain
    Maryam Hammad, Sayed Ali Almahari, Shri Umakanth, Zainab A Toorani · 2024 · Cureus
  89. The Diverse Aspects of Uterine Serous Cancer: an NCI workshop on the status of and opportunities for advancement of research
    Naveena B. Janakiram, Megan A. Clarke, Mihoko Kai, Tiffany A. Wallace, Sandra A. Russo, Toby T. Hecht, Elise C. Kohn, Brandy M. Heckman‐Stoddard · 2024 · JNCI Journal of the National Cancer Institute
  90. ZOOMit diffusion kurtosis imaging combined with diffusion weighted imaging for the assessment of microsatellite instability in endometrial cancer
    Fang Wang, Yafei Wang, Chenjiao Ran, Jing Liang, Lisha Qi, Chen Zhang, Zhaoxiang Ye · 2024 · Abdominal Radiology
  91. Immune cell phenotype in endometrial cancer: from biological significance to clinical utility using Mendelian randomisation analysis
    Lingfang Ye, Beilei Chen, Meng Cen, Qianya Lin · 2025 · Journal of Obstetrics and Gynaecology
  92. Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study
    Rachel Delahunty, Madawa Jayawardana, Rainier Arnolda, Thuan Tzen Koh, Prof Michael S. Hofman, Kym Reid, Julie Lamont, Caitlyn Nguyen-Ngo, Hayley M. Johnston, Nicole A. Brooks et al. · 2026 · Translational Oncology
  93. Elucidating divergent biology in uterine carcinosarcoma
    Vikas Garg, Stephenie D. Prokopec, Simone C. Stone, Sara Pakbaz, Min Li Chen, Bernard Lam, Czin Czin Benito, Michelle McMullen, Ilinca M. Lungu, Samanta Del Rossi et al. · 2025 · Translational Oncology
  94. Applications of single-cell transcriptomics: updated insights in endometrial cancer
    Shuyue Xiao, Huixin Li, Jianyao Liu, Xinyi Xie, Hanzi Xu, Zhen Gong, Shanliang Zhong · 2025 · Clinical & Translational Oncology
  95. Proteomic analysis uncovers biological diversity in molecularly defined endometrial carcinomas
    Dawn R. Cochrane, Gian Luca Negri, Jutta K. Huvila, Forouh Kalantari, David Farnell, Nissreen Mohammad, Emily Thompson, Winnie Yang, Amy M. Lum, Sandra E. Spencer Miko et al. · 2025 · Neoplasia
  96. Endometrial Cancer Genomics
    Mary Ellen Urick, Daphne W. Bell · 2017 · Elsevier eBooks
  97. Molecular Pathology of Endometrioid Adenocarcinoma
    Katherine C. Kurnit, Bojana Djordjevic, Russell R. Broaddus · 2017 · Molecular pathology library
  98. Identification of Distinct Molecular Subtypes of Endometrioid Adenocarcinoma
    Jia Lei, Shuping Yan, Xiangqian Guo, Fengling Wang, Guosen Zhang, Quancheng Kan, Ruixia Guo · 2021 · Frontiers in Genetics
  99. Nueva clasificación molecular del carcinoma de endometrio: impacto en el diagnóstico histopatológico, tratamiento y pronóstico
    Camilo Andrés Pérez Montiel · 2022 · Medunab
  100. Endometrial carcinomas with dyshesive, eosinophilic, and vacuolated (histiocyte-like) tumor cells: a reactive-like phenotype associated with aggressive behavior
    Antonio Travaglino, Damiano Arciuolo, Antonio Raffone, Angela Santoro, Alessia Piermattei, Elena Navarra, Angelo Minucci, Massimo Mascolo, Giulia Scaglione, Nicoletta D’Alessandris et al. · 2022 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin